---
title: "Himalaya Nutravedics India (HNIL) Share Price, Financials & Research"
symbol: "544943"
company: "Himalaya Nutravedics India Ltd"
canonical: "https://tapetide.com/stocks/544943"
isin: "INE1OTR01013"
bse_code: "544943"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-11-05T01:42:50.986Z"
---

# Himalaya Nutravedics India (HNIL)

Canonical page: https://tapetide.com/stocks/544943

## Key Facts

- **Close:** ₹116.00 on 4 Nov 2026
- **Promoter holding:** 68.13% in Sep 2026, a change of -27.01 percentage points from Mar 2026

## Company

- **BSE code:** 544943
- **ISIN:** INE1OTR01013
- **Macro sector:** Healthcare
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Basic industry:** Pharmaceuticals
- **In the F&O segment:** No

## Latest Price

- **Close:** ₹116.00 on 4 Nov 2026

## Key Fundamentals

Price-based figures at the 4 Nov 2026 close · TTM.

- **ROCE:** 52.20%
- **Debt to Equity:** 0.31
- **Book Value:** ₹48.69
- **P/B:** 2.38
- **ROE:** 63.90%
- **Dividend Yield:** 0.00%
- **EBITDA:** ₹8.20 Cr
- **52W High:** ₹167.20
- **52W Low:** ₹111.00

## Key Insights

### Strengths

- Company has a good return on equity (ROE) track record: 3 Years ROE 59.8%

### Weaknesses

- Working capital days have increased from 69.7 days to 105 days

## Technical Indicators

As of 4 Nov 2026.

| Group | Signal | Bearish | Neutral | Bullish |
| --- | --- | ---: | ---: | ---: |
| Overall | Bearish | 5 | 13 | 1 |
| Oscillators | Neutral | 1 | 7 | 1 |
| Moving Averages | Bearish | 4 | 6 | 0 |

### Oscillators: Neutral

| Name | Value | Signal |
| --- | ---: | --- |
| RSI (14) | 46.21 | Neutral |
| MACD (12,26,9) | — | Neutral |
| Stochastic (14,3,3) | 20.79 | Neutral |
| ADX (14) | — | Neutral |
| Williams %R (14) | -94.46 | Bullish |
| ATR (14) | 12.07 | Neutral |
| ROC (12) | -22.46 | Bearish |
| Stoch RSI (14) | — | Neutral |
| UO (7,14,28) | — | Neutral |

### Moving Averages: Bearish

| Name | Value | Signal |
| --- | ---: | --- |
| SMA (10) | 124.18 | Bearish |
| EMA (10) | 123.95 | Bearish |
| SMA (20) | 127.61 | Bearish |
| EMA (20) | 125.90 | Bearish |
| SMA (50) | — | Neutral |
| EMA (50) | — | Neutral |
| SMA (100) | — | Neutral |
| EMA (100) | — | Neutral |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Pivot Points

| Level | Classic | Fibonacci | Camarilla |
| --- | ---: | ---: | ---: |
| R3 | 125.84 | 123.67 | 117.65 |
| R2 | 123.67 | 121.38 | 117.10 |
| R1 | 119.84 | 119.96 | 116.55 |
| PP | 117.67 | 117.67 | 117.67 |
| S1 | 113.84 | 115.38 | 115.45 |
| S2 | 111.67 | 113.96 | 114.90 |
| S3 | 107.84 | 111.67 | 114.35 |

## Growth Rate

Growth computed from the financial statements below. A window with no rate gives the reason instead of a figure.

| Metric | Window | Growth | What it compares |
| --- | --- | ---: | --- |
| Revenue | 3Y | 176% | compounded annual rate, Mar 2023 to Mar 2026 |
| Revenue | 1Y | 105% | fiscal year to Mar 2026 vs the year to Mar 2025 |
| Net profit | 3Y | 267% | compounded annual rate, Mar 2023 to Mar 2026 |
| Net profit | 1Y | 231% | fiscal year to Mar 2026 vs the year to Mar 2025 |
| Operating cash flow | 3Y | — | compounded annual rate, Mar 2023 to Mar 2026. The statements do not go back far enough for this window. |
| Operating cash flow | 1Y | Outflow widened | fiscal year to Mar 2026 vs the year to Mar 2025: -₹1.39 Cr to -₹3.83 Cr. A cash outflow at both ends, larger at the end. |
| Operating margin | 3Y | +5.17 pp | compounded annual rate, Mar 2023 to Mar 2026 |
| Operating margin | 1Y | +4.59 pp | fiscal year to Mar 2026 vs the year to Mar 2025 |

Trailing twelve months: No quarterly results are reported.

## Financial Statements

### Profit & Loss

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: |
| Sales | 2.05 | 14.43 | 21 | 43.06 |
| Expenses | 1.77 | 13.49 | 18.01 | 34.95 |
| Operating Profit | 0.28 | 0.94 | 2.99 | 8.11 |
| OPM % | 13.66% | 6.51% | 14.24% | 18.83% |
| Other Income | 0 | 0 | 0 | 0.05 |
| Interest | 0.02 | 0.18 | 0.32 | 0.35 |
| Depreciation | 0.06 | 0.16 | 0.42 | 0.33 |
| Profit before tax | 0.2 | 0.6 | 2.25 | 7.48 |
| Tax % | 25% | 28.33% | 0.89% | 1.2% |
| Net Profit | 0.15 | 0.43 | 2.23 | 7.39 |
| EPS in Rs | 1.25 | 3.58 | 3.72 | 11.72 |
| Dividend Payout % | 0% | 0% | 0% | 0% |

### Balance Sheet

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: |
| Equity Capital | 0.83 | 0.83 | 4 | 6.31 |
| Reserves | 0.15 | 0.53 | 2.76 | 10.07 |
| Borrowings | 1.32 | 3.24 | 1.76 | 5.13 |
| Other Liabilities | 0.93 | 1.49 | 2.3 | 2.91 |
| Total Liabilities | 3.23 | 6.09 | 10.82 | 24.42 |
| Fixed Assets | 0.58 | 1.5 | 1.29 | 1.03 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0.02 | 0.03 | 0.07 |
| Other Assets | 2.65 | 4.57 | 9.5 | 23.32 |
| Total Assets | 3.23 | 6.09 | 10.82 | 24.42 |

### Cash Flow

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: |
| Cash from Operating Activity | — | -0.55 | -1.39 | -3.83 |
| Cash from Investing Activity | — | -1.1 | -0.23 | -0.06 |
| Cash from Financing Activity | — | 1.84 | 1.44 | 5.27 |
| Net Cash Flow | — | 0.19 | -0.18 | 1.38 |
| Free Cash Flow | — | -1.63 | -1.6 | -3.9 |
| CFO/EBITDA | — | -40 | -46 | -46 |

### Ratios

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | ---: | ---: | ---: | ---: |
| Debtor Days | 169 | 39.21 | 98.03 | 89.77 |
| Inventory Days | 736 | 112 | 96.55 | 143 |
| Days Payable | 60.83 | 27.56 | 37.68 | 11.2 |
| Cash Conversion Cycle | 844 | 124 | 157 | 221 |
| Working Capital Days | 296 | 6.58 | 97.85 | 105 |
| ROCE % | — | 22.61% | 39.18% | 52.15% |

## Shareholding Pattern

### Quarterly Shareholding

Holdings in % of shares; shareholders as a count.

| Holder | Mar 2026 | Sep 2026 |
| --- | ---: | ---: |
| Promoters | 95.14% | 68.13% |
| FIIs | 0.00% | 6.99% |
| DIIs | 0.00% | 0.00% |
| Government | 0.00% | 0.00% |
| Public | 0.00% | 13.98% |
| Others | 4.86% | 10.90% |
| No. of Shareholders | 42 | 42 |

## Documents

### Concalls

| Month | Call documents |
| --- | --- |
| Oct 2026 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3b39f55-c275-4903-a3ef-5dc097ebe4f2.pdf) |

### Exchange filings

| Date | Document | Category |
| --- | --- | --- |
| 2 Nov 2026 | [Intimation Regarding Updation Of Corporate Identification Number (CIN) And Company Master Data On The MCA Portal Pursuant To Listing Of Equity Shares On The BSE SME Platform](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a49eeb7f-b9ac-4077-bc9e-54576ea9c3cf.pdf) | General announcements |
| 17 Oct 2026 | [Reply To The Clarification Sought With Regard To The Price Movement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04ed7737-9828-4539-b9a4-57eeea7d9f95.pdf) | General announcements |
| 16 Oct 2026 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=439dd712-32c3-486f-87ae-6148b17a4223.pdf) | General announcements |
| 4 Oct 2026 | [Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Commercial Suit Filed Against The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1df655fe-b9c1-4708-b4c4-5455f952006c.pdf) | General announcements |
| 3 Oct 2026 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=217af02c-11e9-4655-b8c0-914734699178.pdf) | Intimation |

## Frequently Asked Questions about Himalaya Nutravedics India

### What does Himalaya Nutravedics India Ltd do?

Incorporated in June 2022, Himalaya Nutravedics India Limited is engaged in the manufacturing, marketing, and distribution of Ayurvedic and nutraceutical formulations.

### Where is Himalaya Nutravedics India Ltd (HNIL) listed?

Himalaya Nutravedics India Ltd trades under code 544943 on the BSE.

### Which sector does Himalaya Nutravedics India Ltd belong to?

Himalaya Nutravedics India Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

### What is the 52-week high and low of Himalaya Nutravedics India Ltd?

Over the last 52 weeks Himalaya Nutravedics India Ltd has traded between ₹111 and ₹167.2 as of 4 Nov 2026.

### What is the Return on Equity (ROE) of Himalaya Nutravedics India Ltd?

Himalaya Nutravedics India Ltd reported a return on equity of 63.90%. Its debt-to-equity ratio is 0.31.

## Company Information

Incorporated in June 2022, Himalaya Nutravedics India Limited is engaged in the manufacturing, marketing, and distribution of Ayurvedic and nutraceutical formulations.

- **Face Value:** ₹10

---

Negative figures use an ASCII hyphen-minus (-) so they parse as numbers. Amounts are in Indian rupees; "Cr" is crore (10 million). Dates are Indian Standard Time.

Financial statements, shareholding and filings are as reported by the company. Price, volume and 52-week levels are market data. Technical indicators are computed by Tapetide from daily prices. The Tapetide Score is Tapetide’s own analysis. Analyst ratings and forecasts are the published estimates of third-party analysts, not company statements. The AI sections are generated text.

For research and information only, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Generated 5 Nov 2026, 07:12 IST.